Table 1. Demographic characteristics and clinical symptoms of 1362 inpatients with COVID-2019 in Wuhan, China.
Figures are numbers (percentages) unless stated otherwise.
| Characteristic | All case patients (n = 1362) | Patients with mild illness (n = 734) | Patients with severe illness | |||
|---|---|---|---|---|---|---|
| Subtotal (n = 628) | Survivors of severe illness (n = 91) | Survivors of critical illness (n = 331) | Death (n = 206) | |||
| Male | 685 (50.3) | 336 (45.8) | 349 (55.6) | 43 (47.3) | 170 (51.4) | 136 (66.0) |
| Median(IQR) age(year) | 62 (49–69) | 59 (45–67) | 65 (52–72) | 64 (55–71) | 58 (45–69) | 70 (63–78) |
| Age group(year) | ||||||
| 14–49 | 357 (26.2) | 229 (31.2) | 128 (20.4) | 16 (17.6) | 105 (31.7) | 7 (3.4) |
| 50–59 | 263 (19.3) | 144 (19.6) | 119 (18.9) | 19 (20.9) | 68 (20.5) | 32 (15.5) |
| 60–69 | 403 (29.6) | 230 (31.3) | 173 (27.5) | 27 (29.7) | 82 (24.8) | 64 (31.1) |
| ≥70 | 339 (24.9) | 131 (17.8) | 208 (33.1) | 29 (31.9) | 76 (23.0) | 103 (50.0) |
| Comorbidities a | 704 (51.7) | 336 (45.8) | 368 (58.6) | 54 (59.3) | 163 (49.2) | 151 (73.3) |
| Hypertension | 413 (30.3) | 192 (26.2) | 221 (35.2) | 37 (40.7) | 95 (28.7) | 89 (43.2) |
| Diabetes | 194 (14.2) | 97 (13.2) | 97 (15.4) | 15 (16.5) | 45 (13.6) | 37 (18.0) |
| Coronary | 104 (7.6) | 42 (5.7) | 62 (9.9) | 8 (8.8) | 26 (7.9) | 28 (13.6) |
| Chronic respiratory disease | 90 (6.6) | 43 (5.9) | 47 (7.5) | 8 (8.8) | 13 (3.9) | 26 (12.6) |
| Chronic digestive disease | 73 (5.4) | 39 (5.3) | 34 (5.4) | 2 (2.2) | 15 (4.5) | 17 (8.3) |
| Chronic kidney disease | 53 (3.9) | 21 (2.9) | 32 (5.1) | 1 (1.1) | 18 (5.4) | 13 (6.3) |
| Carcinoma | 30 (2.2) | 12 (1.6) | 18 (2.9) | 3 (3.3) | 5 (1.5) | 10 (4.9) |
| Others§ | 144 (10.6) | 66 (9.0) | 78 (12.4) | 10 (11.0) | 37 (11.2) | 31 (15.0) |
| Fever though clinical course (%) | 1179 (86.6) | 616 (83.9) | 563 (89.6) | 77 (84.6) | 294 (88.8) | 192 (93.2) |
| Temperature at admission | ||||||
| <38. 5°C | 1048/1179 (88.9) | 559/616 (90.7) | 489/563 (86.9) | 69/77 (89.6) | 257/294 (87.4) | 163/192 (84.9) |
| ≥38.5°C | 123/1179 (10.4) | 56/616 (9.1) | 67/563 (11.9) | 8/77 (10.4) | 36/294 (12.2) | 23/192 (12.0) |
| Peak temperature | ||||||
| <38.5°C | 437/1179 (37.1) | 245/616 (39.8) | 192/563 (34.1) | 29/77 (37.7) | 100/294 (34.0) | 63/192 (32.8) |
| ≥38.5°C | 742/1179 (62.9) | 371/616 (60.2) | 371/563 (65.9) | 48/77 (62.3) | 194/294 (66.0) | 129/192 (67.2) |
| Symptoms | ||||||
| Cough | 1120 (82.2) | 594 (80.9) | 526 (83.8) | 80 (87.9) | 282 (85.2) | 164 (79.6) |
| Hypoxia symptoms | 953 (70.0) | 474 (64.6) | 479 (76.3) | 62 (68.1) | 241 (72.8) | 176 (85.4) |
| Chest tightness | 646 (47.4) | 348 (47.4) | 298 (47.5) | 54 (59.3) | 145 (43.8) | 99 (48.1) |
| Breath shortness | 580 (42.6) | 272 (37.1) | 308 (49.0) | 39 (42.9) | 157 (47.4) | 112 (54.4) |
| Dyspnea | 481 (35.3) | 193 (26.3) | 288 (45.9) | 24 (26.4) | 127 (38.4) | 137 (66.5) |
| Sputum production | 709 (52.1) | 377 (51.4) | 332 (52.9) | 52 (57.1) | 179 (54.1) | 101 (49.0) |
| Fatigue | 675 (49.6) | 343 (46.7) | 332 (52.9) | 48 (52.7) | 177 (53.5) | 107 (51.9) |
| Anorexia | 610 (44.8) | 278 (37.9) | 332 (52.9) | 37 (40.7) | 176 (53.2) | 119 (57.8) |
| Diarrhea | 409 (30.0) | 231 (31.5) | 178 (28.3) | 25 (27.5) | 92 (27.8) | 61 (29.6) |
| Muscle pain | 258 (18.9) | 147 (20.0) | 111 (17.7) | 16 (17.6) | 64 (19.3) | 31 (15.0) |
| Nausea | 166 (12.2) | 100 (13.6) | 66 (10.5) | 7 (7.7) | 38 (11.5) | 21 (10.2) |
| Headache | 150 (11.0) | 83 (11.3) | 67 (10.7) | 10 (11.0) | 37 (11.2) | 20 (9.7) |
| Vomiting | 116 (8.5) | 58 (7.9) | 58 (9.2) | 10 (11.0) | 24 (7.3) | 24 (11.7) |
| Sore throat | 89 (6.5) | 51 (6.9) | 38 (6.1) | 7 (7.7) | 26 (7.9) | 5 (2.4) |
Notes. All patients who died were included in critical cases.
a Comorbidities listed are not mutually exclusive.
§ Other comorbidities including mental diseases, gynecological diseases, menopausal syndrome, cataracts, hyperthyroidism, hypothyroidism, Alzheimer's disease, paralysis, Parkinson's disease, arthritis, spinal diseases, gout, allergic rhinitis, skin diseases, blood diseases, other cardiovascular and cerebrovascular diseases.